Simmons, Aaron B.
Bretz, Colin A.
Wang, Haibo
Kunz, Eric
Hajj, Kassem
Kennedy, Carson
Yang, Zhihong
Suwanmanee, Thipparat
Kafri, Tal
Hartnett, M. Elizabeth
Funding for this research was provided by:
National Eye Institute (EY015130, EY017011, EY024234, EY014800)
Research to Prevent Blindness
National Institute of Diabetes and Digestive and Kidney Diseases (DK058702)
National Heart, Lung, and Blood Institute (HL128119)
Article History
Received: 9 March 2018
Accepted: 26 April 2018
First Online: 5 May 2018
Change Date: 25 June 2018
Change Type: Correction
Change Details: The article “Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy”, written by “Aaron B. Simmons, Colin A. Bretz, Haibo Wang, Eric Kunz, Kassem Hajj, Carson Kennedy, Zhihong Yang, Thipparat Suwanmanee, Tal Kafri and M. Elizabeth Hartnett”, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 05 May 2018 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 20 June 2018 to © The Author(s) 2018 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (ExternalRef removed), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.